Article info
Original article
Parkin and PINK1 mutations in early-onset Parkinson’s disease: comprehensive screening in publicly available cases and control
- Dr S W Scholz, Laboratory of Neurogenetics, National Institute on Aging, 35 Convent Drive, 20892 Bethesda, MD, USA; scholzs{at}mail.nih.gov
Citation
Parkin and PINK1 mutations in early-onset Parkinson’s disease: comprehensive screening in publicly available cases and control
Publication history
- Received October 16, 2008
- Revised January 1, 2009
- Accepted January 27, 2009
- First published April 6, 2009.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group Ltd